Track topics on Twitter Track topics that are important to you
230 Constitution Drive
United States of America
Phone: 650 473 7700
Fax: 650 473 7750
Aleksandra Rizo has been appointed chief medical officer of Geron (NASDAQ: GERN). Rizo comes to the Menlo Park, CA, drug developer from Summit, NJ-based Celgene (NASDAQ: CELG), where she was executive...
Four years after Geron landed a pharmaceutical partner to co-develop its lead drug, the Menlo Park, CA, biotech is now moving forward with the compound on its own. Janssen Biotech is ending the collab...
Geron, which saw shares fall 70% by market's open Thursday, said it will power on with imetelstat's development, with a Phase 3 testing planned for mid-2019.
Geron and Johnson and Johnson’s subsidiary, Janssen Biotech, have announced they have terminated their partnership of a drug development for two different blood disorders. The post Geron and Janssen...
Geron and Johnson & Johnson’s subsidiary, Janssen Biotech, have terminated their partnership on development of a drug for two different blood disorders. The post Geron Cancels Janssen Collabora...
In November 2014, Janssen signed an exclusive worldwide collaboration and license agreement with Geron for the development and commercialization of imetelstat in oncology, including hematologic myeloi...
WASHINGTON (dpa-AFX) - Geron Corp. (GERN) on Monday announced changes to the leadership structure of the company's Board of Directors. The company noted that for personal reasons, effective Decemb...
Johnson & Johnson's Janssen Biotech will end a licensing partnership with Geron Corp., returning rights to the biotech’s sole product candidate, imetelstat.
Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The ...
As a leader in cancer precision medicine in China, Genetron is practicing the research and development concept of âexploration, discovery, application and changeâ. Genet...
Asterias Biotherapeutics is a subsidiary of BioTime, Inc., whose mission is to acquire and develop best in class cell therapy product candidates. Our first acquisition was the ste...
Geron Corporation is a biopharmaceutical company focused on discovering and developing therapeutic and diagnostic products to treat cancer and other age-related degenerative diseases. The Company is u...
T.A. Sciences www.TASciences.com is the first company in the world to offer its clients the ability to fight aging through the emerging science of telomere biology. T.A. Sciences was founded by Noel T...
We have published hundreds of Geron news stories on BioPortfolio along with dozens of Geron Clinical Trials and PubMed Articles about Geron for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Geron Companies in our database. You can also find out about relevant Geron Drugs and Medications on this site too.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers) - Mouth cancer can develop on the lip, the tongue, the floor...
Track and monitor developments in stem cell research and commercial development. Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry. BioPort...